Article Information
History
- July 22, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Aaron J. Bernstein1,2,
- Renske Keeman3,
- Amber Hurson4,
- Fiona M. Blows5,
- Manjeet K. Bolla6,
- Jodi L. Miller7,
- Roger Milne8,9,10,
- Hugo Horlings11,
- Alexandra J. van den Broek3,
- Clara Bodelon12,
- James Hodge12,
- Alpa Patel13,
- Lauren R. Teras12,
- Federico Canzian14,
- Rudolf Kaaks14,
- Hermann Brenner14,
- Ben Schöttker15,
- Sabine Behrens14,
- Jenny Chang-Claude14,
- Tabea Maurer16,
- Nadia Obi17,18,
- Fergus Couch19,
- H. Raza Ali5,
- Carlos Caldas20,
- Irene Andrulis21,
- Gord Glendon21,
- Anna Marie Mulligan22,
- Wilma Mesker23,
- Agnes Jager24,
- Annette Heemskerk-Gerritsen24,
- Peter Devilee23,
- Scott M. Lawrence25,
- Jolanta Lissowska26,
- Karun Mutreja25,
- Thomas Ahearn4,
- Stephen Chanock4,
- Maire A. Duggan27,
- Diana Eccles28,
- J. Louise Jones29,
- Will Tapper28,
- Antoinette Hollestelle30,
- Maartje Hooning30,
- John Martens31,
- Carolien H.M. van Deurzen32,
- Angela Cox33,
- Simon S. Cross33,
- Mikael Hartman34,
- Jingmei Li35,
- Thomas C. Putti34,
- Ute Hamann36,
- Muhammad Rashid36,
- Ania Jakubowska37,38,
- Nicki Camp39,
- Melissa H. Cessna40,
- Amy Berrington de Gonzalez41,
- Katarzyna Bialkowska38,
- Jacek Gronwald38,
- Jan Lubiński38,
- Siddhartha Yadav42,
- Pietro Lio43,
- Doug F. Easton6,
- Mustapha Abubakar*,4,
- Montse Garcia-Closas*,41,
- Paul D.P. Pharoah*,44,† and
- Marjanka K. Schmidt*,45
- 1Office of Drug Development Partnership Programs, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA
- 2Office of Data Science Strategy, Office of the Director, National Institutes of Health, Bethesda, MD, USA
- 3Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
- 4Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
- 5Department of Oncology, University of Cambridge, Cambridge, UK
- 6Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
- 7Histopathology Core, CRUK Cambridge Institute, Cambridge, UK
- 8Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia
- 9Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
- 10Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia
- 11Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
- 12Department of Population Sciences, American Cancer Society, Atlanta, GA, USA
- 13American Cancer Society, Atlanta, GA, USA
- 14Deutsches Krebsforschungszentrum, Heidelberg, Germany
- 15Division of Clinical Epidemiology and Aging Research, Deutsches Krebsforschungszentrum, Heidelberg, Germany
- 16Center for Psychosocial Medicine, Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 17Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 18Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 19Mayo Clinic, Rochester, MN, USA
- 20Department of Clinical Biochemistry and Institute for Metabolic Science, School of Clinical Medicine, University of Cambridge, Cambridge, UK
- 21Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada
- 22Department of Laboratory Medicine and Pathobiology, University Health Network, University of Toronto, Toronto, Canada
- 23Leiden University Medical Centre, Leiden, The Netherlands
- 24Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands
- 25Molecular and Digital Pathology Laboratory, Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick, MD, USA
- 26Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie, Warsaw, Poland
- 27Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada
- 28University of Southampton, Southampton, UK
- 29Barts Cancer Institute, Queen Mary University of London, London, UK
- 30Dept of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands
- 31Deptartment of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands
- 32Department of Pathology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands
- 33University of Sheffield, Sheffield, UK
- 34National University of Singapore, Singapore
- 35Genome Institute of Singapore (GIS), Agency for Science Technology and Research, Singapore
- 36Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum, Heidelberg, Germany
- 37Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University in Szczecin, Szczecin, Poland
- 38Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland
- 39Huntsman Cancer Institute and Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA
- 40Department of Pathology and Intermountain Biorepository, Intermountain Heath, Salt Lake City, UT, USA
- 41Institute of Cancer Research, London, UK
- 42Department of Oncology, Mayo Clinic, Rochester, MN, USA
- 43Department of Computer Science and Technology, University of Cambridge, Cambridge, UK
- 44Department of Computational Biology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 45Netherlands Cancer Institute, Amsterdam, The Netherlands
- ↵†Correspondence to: Paul D.P. Pharoah, paul.pharoah{at}cshs.org
↵* contributed equally
Posted July 22, 2024.
Spatially-resolved tumour infiltrating immune cells and prognosis in breast cancer
